Atlas Trials

Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects

Clinical trial NCT02318836 · COMPLETED

Trial details

NCT number
NCT02318836
Sponsor
USWM, LLC (dba US WorldMeds)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Failure
Start date
2014-06-01
Primary completion
2014-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.